As ageing affects how people handle packs, senior-friendly design—better grips, clearer labels and safe, low-force ...

Teva Pharmaceuticals has announced new real-world data showing that AUSTEDO (deutetrabenazine) tablets and AUSTEDO XR ...

In a new cohort of 27 adults from the IMPACT-TD Registry, up to 77% of participants reported improvements in aspects of their ...

The new pill, orforglipron, is a GLP-1 agonist, a type of medication which helps lower blood sugar levels, slows the ...

Positive results mark an important step forward in efforts to develop effective treatments for children with drug-resistant TB COPENHAGEN, Denmark, Nov. 19, 2025 /PRNewswire/ -- New interim data from ...

Joy: The AI companion for seniors, developed to have empathetic, supportive conversations that increase independence and wellbeing. Joy plays an integral role in the user experience of JoyReceptionist ...

Retirement doesn’t mark the end of spending; it marks the beginning of spending wisely. Many boomers are focusing on ...

The economic consequences are staggering. Formerly incarcerated individuals face a 51.7 percent wage penalty, costing the U.S ...

A McGill University clinical trial found that digital brain training can restore key brain functions that fade with age.

The ARTISTRY-1 Phase III trial demonstrated that a single-tablet regimen of bictegravir 75 mg/lenacapavir 50 mg maintains viral suppression and simplifies therapy for people living with HIV, ...

Gilead Sciences has announced positive topline results from the Phase 3 ARTISTRY-1 trial. The open-label trial evaluated the treatment responses of adults with HIV who ...